1. Home
  2. RHI vs ARQT Comparison

RHI vs ARQT Comparison

Compare RHI & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Robert Half Inc.

RHI

Robert Half Inc.

HOLD

Current Price

$28.24

Market Cap

2.8B

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$30.12

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RHI
ARQT
Founded
1948
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
RHI
ARQT
Price
$28.24
$30.12
Analyst Decision
Hold
Strong Buy
Analyst Count
6
7
Target Price
$36.00
$24.83
AVG Volume (30 Days)
1.8M
1.8M
Earning Date
01-28-2026
02-24-2026
Dividend Yield
8.47%
N/A
EPS Growth
N/A
N/A
EPS
1.54
N/A
Revenue
$5,458,499,000.00
$317,929,000.00
Revenue This Year
N/A
$85.51
Revenue Next Year
$0.94
$30.74
P/E Ratio
$18.07
N/A
Revenue Growth
N/A
129.21
52 Week Low
$25.22
$11.13
52 Week High
$72.10
$31.77

Technical Indicators

Market Signals
Indicator
RHI
ARQT
Relative Strength Index (RSI) 57.94 57.63
Support Level $26.53 $28.75
Resistance Level $28.26 $30.60
Average True Range (ATR) 0.82 1.22
MACD 0.07 -0.04
Stochastic Oscillator 75.82 82.16

Price Performance

Historical Comparison
RHI
ARQT

About RHI Robert Half Inc.

Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: